AIkido Pharma Inc. - FORM 10-K - EX-32.2 - March 30, 2015

Attached files

file filename
EX-31.2 - AIkido Pharma Inc.ex31-2.htm
EX-21.1 - LIST OF SUBSIDIARIES - AIkido Pharma Inc.ex21-1.htm
EX-23.1 - CONSENT OF MARCUM LLP, INDEPENDENT AUDITORS - AIkido Pharma Inc.ex23-1.htm
EX-31.1 - AIkido Pharma Inc.ex31-1.htm
EX-32.1 - AIkido Pharma Inc.ex32-1.htm
EX-10.26 - LETTER OF AGREEMENT, DATED JANUARY 6, 2014, BETWEEN SPHERIX INCORPORATED AND CHORD ADVISORS, LLC - AIkido Pharma Inc.ex10-26.htm
EXCEL - IDEA: XBRL DOCUMENT - AIkido Pharma Inc.Financial_Report.xls
10-K - FORM 10-K - AIkido Pharma Inc.spex10k_dec312014.htm
EX-10.27 - LETTER OF AGREEMENT, DATED APRIL 11, 2014, BETWEEN SPHERIX INCORPORATED AND CHORD ADVISORS, LLC - AIkido Pharma Inc.ex10-27.htm
Exhibit 32.2

Certification of
Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


I, Richard Cohen, Chief Financial Officer of Spherix Incorporated (the “Company”), in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Annual Report on Form 10-K for the period ended December 31, 2014 (the “Report”) filed with the Securities and Exchange Commission:

 
· Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


 
· The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Richard Cohen
Richard Cohen
Chief Financial Officer
March 30, 2015
 
A signed copy of this written statement required by Section 906 has been provided to Spherix Incorporated and will be retained by Spherix Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.

Stock widget

Investing forum

AIkido Pharma Inc. Reports